David Sarrió
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 15
- Cancer Cells and Metastasis 7
- HER2/EGFR in Cancer Research 6
- Co-authors
- Gema Moreno‐BuenoDavid HardissonJosé PalaciosAmparo CanoSocorro Marıá Rodríguez-PinillaFrancisco Calero CaleroAnnamaria LocascioM. Ángela Nieto
- Journals
- Oncogene (5 papers)Modern Pathology (4 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)The American Journal of Surgical Pathology (2 papers)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
David Sarrió
36 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 1.3k
- Oncology 2.0k
- Molecular Biology 2.6k
- Obstetrics and Gynecology 245
- Pathology and Forensic Medicine 543
Countries citing papers authored by David Sarrió
This map shows the geographic impact of David Sarrió's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sarrió with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sarrió more than expected).
Fields of papers citing papers by David Sarrió
This network shows the impact of papers produced by David Sarrió. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sarrió. The network helps show where David Sarrió may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Sarrió, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 26 | |
| 5 | 2021 | 39 | |
| 6 | 2016 | 20 | |
| 7 | 2012 | 90 | |
| 8 | 2009 | 52 | |
| 9 | Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype Hit paper breakdown → | 2008 | 842 |
| 10 | 2007 | 44 | |
| 11 | 2006 | 261 | |
| 12 | 2006 | 215 | |
| 13 | 2006 | 277 | |
| 14 | 2006 | 54 | |
| 15 | 2006 | 43 | |
| 16 | 2003 | 170 | |
| 17 | 2003 | 98 | |
| 18 | 2003 | 66 | |
| 19 | 2002 | 481 | |
| 20 | 2001 | 12 |
About David Sarrió
David Sarrió is a scholar working on Oncology, Immunology and Allergy, Cancer Research, Reproductive Medicine and Molecular Biology, having authored 37 papers that have together received 4.5k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (11 papers), Cancer Cells and Metastasis (7 papers), Cancer-related gene regulation (7 papers), HER2/EGFR in Cancer Research (6 papers), Kruppel-like factors research (6 papers), Inflammasome and immune disorders (5 papers), Epigenetics and DNA Methylation (4 papers) and Breast Lesions and Carcinomas (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (2.0k citations), Molecular Biology (2.6k citations), Obstetrics and Gynecology (245 citations) and Pathology and Forensic Medicine (543 citations). David Sarrió has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include Gema Moreno‐Bueno, David Hardisson, José Palacios, Amparo Cano, Socorro Marıá Rodríguez-Pinilla, José Palacios, Francisco Calero Calero, Annamaria Locascio, M. Ángela Nieto and Marı́a José Blanco. Their work appears in journals such as Oncogene, Modern Pathology, Cancer Research, Clinical Cancer Research and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.